In an NSTEMI patient with hypotension (90/60 mm Hg) receiving an Isoket (isosorbide dinitrate) infusion prepared as 90 mg in 60 mL and running at 5 mL/hr, should the drip be stopped or reduced to 2–3 mL/hr or 1 mL/hr?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 25, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the infusion rate of Isoket (Isosorbide dinitrate) in 90 ml of Peripheral Nutrition Support Solution (PNSS) for a 70kg patient?

How to initiate an Isoket (Isosorbide dinitrate) infusion?

What is the initial infusion rate in cc/hr of Isoket (Isosorbide dinitrate) for a patient?

How is Isosorbide Dinitrate (ISDN) drip administered?

What infusion rate (mL/hr) should be set for a 50 kg female receiving 10 mg isosorbide dinitrate (Isoket) diluted in 90 mL of 5% dextrose in water (D5W) via a Soluset?

Do serotonin‑norepinephrine reuptake inhibitors (SNRIs) have a role in treating ADHD or its comorbid depression/anxiety, and what is the evidence and recommended dosing?

When should calcium gluconate be used for supplementation, and what are the recommended intravenous and oral dosing regimens for acute symptomatic hypocalcemia versus chronic oral calcium replacement?

What is the recommended acute management for a patient presenting with sinus rhythm and horizontal or down‑sloping ST‑segment depression indicating subendocardial myocardial ischemia?

In a patient with sinus tachycardia and labs showing normal free thyroxine (FT4) and thyroid‑stimulating hormone (TSH) but low free triiodothyronine (FT3), what is the likely diagnosis and appropriate management?

In a patient with non‑ST‑segment elevation myocardial infarction and hypotension (blood pressure ~90/60 mmHg), what are the guidelines for using isosorbide dinitrate (Isoket)?

In a 52‑year‑old female with Down syndrome who has Parkinsonian syndrome confirmed by PET (positron emission tomography) scan and Alzheimer’s disease confirmed by laboratory testing (PT 217), which condition should be treated first?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.